Global Digital Biomarkers Market is Set to Witness Significant Growth of 35% during 2021 to 2026Posted by Tejashri Khade on October 21st, 2022 Advanced analytics and artificial intelligence (AI) algorithms are used by digital biomarkers to analyze data in ways that are not possible for humans to do alone. The Global Digital Biomarkers Market is set to witness a significant CAGR of 35% from 2021 to 2026. Some of the important drivers propelling the global digital biomarkers market are high investments in R&D, increasing usage of digital tools such as smartphones and wearables, development of novel products by market players, high cost involved in drug development, and rising demand for mobile health apps. High investments and funding to grow novel technologies to fuel its high demand Future treatments and diagnostic protocols for certain indications, including cancer, amyotrophic lateral sclerosis (ALS), and Alzheimer's disease, are expected to rely heavily on digital biomarkers. High growth of the digital biomarkers market has led to a number of investments and funding activities to accelerate research on digital biomarkers. Some of these are listed below:
Explore Premium Report on Digital Biomarkers Market @ https://meditechinsights.com/digital-biomarkers-market/ Big pharma companies and government bodies extend focus on digital biomarkers to boost the acceptance of digital biomarkers market Digital biomarkers are much more than fitness trackers and smartwatches. The digital biomarkers market has witnessed a number of big pharma companies partnering with innovative digital health start-ups to improve the acceptance of this technology and co-develop advanced solutions. With the massive burden caused by Covid-19 pandemic, government bodies have also shown interest for the development of digital biomarker based therapeutic solution. The following is a list of some recent advances in this area:
Competitive Landscape Analysis of Digital Biomarkers Market The global digital biomarkers market is marked by the presence of key players such as ActiGraph, LLC (US), AliveCor Inc. (US), Amgen Inc. (US), Biogen Inc. (US), AiCure (US), AstraZeneca (UK), and others. For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/ About Medi-Tech Insights Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services. Contact: Ruta Halde Associate, Medi-Tech Insights +32 498 86 80 79 info@meditechinsights.com Like it? Share it!More by this author |